Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
-
-
Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025
On Jan. 8, 2026, Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier…
-
Biology | Diagnostics | Disease | Oncology | Therapeutics
New research uncovers critical DNA repair mechanism during cell division
On Jan. 8, 2026, a major advance in cell biology has revealed how our cells safeguard their genetic…
-
How some people get drunk from their own gut bacteria
On Jan. 8, 2026, researchers reported results from a study on the largest cohort of autobrewery syndrome (ABS)…
-
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
-
Widely used pesticide linked to more than doubled Parkinson’s risk
On Jan. 7, 2026, a study from the University of California, Los Angeles (UCLA) Health found that long-term…
-
Diagnostics | Environmental | EPA | Forestry | Infectious Disease | Non-Profit Research | Oncology | Therapeutics
respiratory infections remain the world’s leading infectious cause of death
On Jan. 6, 2026, a systematic analysis for the Global Burden of Disease Global study shows that lower…
-
Amgen Acquires Dark Blue Therapeutics for $840 Million
On Jan. 6, 2026, Amgen announced its acquisition of Dark Blue Therapeutics, a privately held biotechnology company based…
-
Some antibodies outmaneuver germs from sticking to cells
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
-
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
-
Flu season surged in the U.S. over the holiday and already rivals last winter’s harsh epidemic
On Jan. 5, 2026, U.S. flu infections surged over the holidays, and health officials are calling it a…
-
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
-
Biotechnology | CMO | CRO | Genomics | Therapeutics | Vaccine
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
-
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
-
Novartis and U.S. government reach agreement on lowering drug prices
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
-
Biotechnology | Diagnostics | HIV | Therapeutics | Vaccine | WHO | Women's Health
WHO validates Brazil for eliminating mother-to-child transmission of HIV
On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
-
Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
On Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
-
Space Station Research Supports New FDA-Approved Cancer Therapy
On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
-
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
-
Israeli, US scientists uncover viral switch that could help defeat antibiotic resistance
On Dec. 18, 2025, scientists at the Hebrew University of Jerusalem revealed that bacteriophages use a small RNA…
-
University Engineers create robots barely visible to the naked eye that operate autonomously
On Dec. 17, 2025, researchers at the University of Pennsylvania’s (UPenn) School of Engineering and Applied Science, and…
-
Adaptive Inks deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases woth $890 Million
On Dec. 15, 2025, Adaptive Biotechnologies announced it has signed two non-exclusive deals with Pfizer to support research…
-
Agriculture | Biotechnology | Chemistry | Diagnostics | Energy | Environmental | Infectious Disease | Medical Device | Non-Profit Research | Nutraceuticals | Therapeutics | U.S. Congress
Montana State University announced as site of U.S. Patent and Trademark office
On Dec. 15, 2025, the U.S. Department of Commerce announced that Montana State University will be home to…
-
Japanese Scientists Reproduce human neural circuits showing crucial role of the thalamus
On Dec. 12, 2025, a Japanese research team announced it has successfully reproduced the human neural circuit in…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves Two Oral Therapies to Treat Gonorrhea
On Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
-
FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program
On Dec. 11, 2025, USAntibiotics, the country’s only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), announced…
-
FDA | Medicine | Therapeutics
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…
-
UCLA team discovers how to target ‘undruggable’ protein that fuels aggressive leukemia
On Dec. 9, 2025, researchers at the UCLA Health Jonsson Comprehensive Cancer Center announced they have identified a…
-
Agriculture | Artificial Intelligence | Biotechnology | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Canada launches $1.7 billion initiative to recruit world-leading researchers
On Dec. 9, 2025, officials from the Canada Economic Development for Quebec Regions, and the Minister of Industry,…
